N-[3-[4-(cyclopropylsulfonylamino)pyrimidin-2-yl]-3-bicyclo[3.1.0]hexanyl]-4-(6-ethoxypyrazin-2-yl)benzamide
C26H28N6O4S — CID 177175415
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[4-(cyclopropylsulfonylamino)pyrimidin-2-yl]-3-bicyclo[3.1.0]hexanyl]-4-(6-ethoxypyrazin-2-yl)benzamide
N-[3-[4-(cyclopropylsulfonylamino)pyrimidin-2-yl]-3-bicyclo[3.1.0]hexanyl]-4-(6-ethoxypyrazin-2-yl)benzamide (PubChem CID 177175415) has the molecular formula C26H28N6O4S and a molecular weight of 520.62 g/mol. Its IUPAC name is N-[3-[4-(cyclopropylsulfonylamino)pyrimidin-2-yl]-3-bicyclo[3.1.0]hexanyl]-4-(6-ethoxypyrazin-2-yl)benzamide.
Molecular Properties
| Compound Name | N-[3-[4-(cyclopropylsulfonylamino)pyrimidin-2-yl]-3-bicyclo[3.1.0]hexanyl]-4-(6-ethoxypyrazin-2-yl)benzamide |
|---|---|
| PubChem CID | 177175415 |
| Molecular Formula | C26H28N6O4S |
| Molecular Weight | 520.62 g/mol |
| Exact Mass | 520.19 |
| IUPAC Name | N-[3-[4-(cyclopropylsulfonylamino)pyrimidin-2-yl]-3-bicyclo[3.1.0]hexanyl]-4-(6-ethoxypyrazin-2-yl)benzamide |
| SMILES | CCOc1cncc(-c2ccc(C(=O)NC3(c4nccc(NS(=O)(=O)C5CC5)n4)CC4CC4C3)cc2)n1 |
| InChI | InChI=1S/C26H28N6O4S/c1-2-36-23-15-27-14-21(29-23)16-3-5-17(6-4-16)24(33)31-26(12-18-11-19(18)13-26)25-28-10-9-22(30-25)32-37(34,35)20-7-8-20/h3-6,9-10,14-15,18-20H,2,7-8,11-13H2,1H3,(H,31,33)(H,28,30,32) |
| InChIKey | HFUTWFLVAASQLR-UHFFFAOYSA-N |
| XLogP | 3.29 |
| TPSA | 136.06 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 520.62 |
| LogP ≤ 5 | 3.29 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177175415 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.